Real-world data on the effectiveness and safety of teriflunomide in patients with relapsing–remitting multiple sclerosis: The EFFECT study

Real-world data on the effectiveness and safety of teriflunomide in patients with relapsing–remitting multiple sclerosis: The EFFECT study

Introduction: The objective of the present study was to evaluate the effectiveness and safety of teriflunomide in relapsing–remitting multiple sclerosis (RRMS) patients treated in a real-world setting. Methods: This retrospective study was conducted at neurology departments of 15 hospitals in 2 Span...

Full description

Bibliographic Details
Main Authors: Mª.C. Durán Herrera, M.D. Sánchez, E. Aguera, C. Muñoz, A. Alonso, C. Arnal, J. Dotor, J. Barrero, M. Gómez, J. Caballero-Villarraso, L.L. Hernández, E. Cancho, M. Romera, T. Gavilán, F. Castellanos, R. Espinosa, L. Forero, R. Querol-Pascual, A.M. Roa-Montero, V.P. de Colosía Rama, A.G. Plata, F.P. Parrado
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Neurology Perspectives
Subjects:
Datos del mundo real
Evidencia del mundo real
Esclerosis múltiple remitente-recurrente
Teriflunomida
tratamiento oral modificador de la enfermedad
Online Access:http://www.sciencedirect.com/science/article/pii/S2667049622000345

Internet

http://www.sciencedirect.com/science/article/pii/S2667049622000345

Similar Items